156 related articles for article (PubMed ID: 24256349)
1. Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC.
Moore N; Salvo F; Duong M; Blin P; Pariente A
Expert Opin Drug Saf; 2014 Feb; 13(2):167-79. PubMed ID: 24256349
[TBL] [Abstract][Full Text] [Related]
2. NSAIDs and serious cardiovascular disorders: especially cox-2 inhibitors and diclofenac.
Prescrire Int; 2016 Jan; 25(167):14-6. PubMed ID: 26942254
[TBL] [Abstract][Full Text] [Related]
3. Ibuprofen: pharmacology, efficacy and safety.
Rainsford KD
Inflammopharmacology; 2009 Dec; 17(6):275-342. PubMed ID: 19949916
[TBL] [Abstract][Full Text] [Related]
4. Over-the-counter ibuprofen and risk of gastrointestinal bleeding complications: a systematic literature review.
Michels SL; Collins J; Reynolds MW; Abramsky S; Paredes-Diaz A; McCarberg B
Curr Med Res Opin; 2012 Jan; 28(1):89-99. PubMed ID: 22017233
[TBL] [Abstract][Full Text] [Related]
5. Cardiorenal Safety of OTC Analgesics.
White WB; Kloner RA; Angiolillo DJ; Davidson MH
J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):103-118. PubMed ID: 29421936
[TBL] [Abstract][Full Text] [Related]
6. Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews.
Odom DM; Mladsi DM; Saag KG; Sherif BN; Miles L; Ronquest N; Wang J
Clin Ther; 2014 Jun; 36(6):906-17. PubMed ID: 24863260
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.
McGettigan P; Henry D
PLoS Med; 2011 Sep; 8(9):e1001098. PubMed ID: 21980265
[TBL] [Abstract][Full Text] [Related]
8. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.
Lewis JD; Kimmel SE; Localio AR; Metz DC; Farrar JT; Nessel L; Brensinger C; McGibney K; Strom BL
Gastroenterology; 2005 Dec; 129(6):1865-74. PubMed ID: 16344055
[TBL] [Abstract][Full Text] [Related]
9. Ibuprofen: from invention to an OTC therapeutic mainstay.
Rainsford KD
Int J Clin Pract Suppl; 2013 Jan; (178):9-20. PubMed ID: 23163543
[TBL] [Abstract][Full Text] [Related]
10. Responsible self-medication: perceived risks and benefits of over-the-counter analgesic use.
Stosic R; Dunagan F; Palmer H; Fowler T; Adams I
Int J Pharm Pract; 2011 Aug; 19(4):236-45. PubMed ID: 21733011
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics.
Moore N; Scheiman JM
Postgrad Med; 2018 Mar; 130(2):188-199. PubMed ID: 29417856
[TBL] [Abstract][Full Text] [Related]
12. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease.
Ray WA; Varas-Lorenzo C; Chung CP; Castellsague J; Murray KT; Stein CM; Daugherty JR; Arbogast PG; García-Rodríguez LA
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):155-63. PubMed ID: 20031832
[TBL] [Abstract][Full Text] [Related]
14. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs.
Wilcox CM; Cryer B; Triadafilopoulos G
J Rheumatol; 2005 Nov; 32(11):2218-24. PubMed ID: 16265706
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
Biskupiak JE; Brixner DI; Howard K; Oderda GM
J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.
Varas-Lorenzo C; Maguire A; Castellsague J; Perez-Gutthann S
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):366-76. PubMed ID: 16897817
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of nabumetone, naproxen, piroxicam, and diclofenac on rat gastric irritancy following acute exposure to OTC non-steroidal anti-inflammatory agents and other gastric irritants.
Carryl OR; Spangler RS
Scand J Rheumatol; 1995; 24(6):336-41. PubMed ID: 8610216
[TBL] [Abstract][Full Text] [Related]
18. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
van Staa TP; Rietbrock S; Setakis E; Leufkens HG
J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902
[TBL] [Abstract][Full Text] [Related]
19. Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.
Duong M; Salvo F; Pariente A; Abouelfath A; Lassalle R; Droz C; Blin P; Moore N
Br J Clin Pharmacol; 2014 May; 77(5):887-95. PubMed ID: 24102791
[TBL] [Abstract][Full Text] [Related]
20. Exceeding the daily dosing limit of nonsteroidal anti-inflammatory drugs among ibuprofen users.
Kaufman DW; Kelly JP; Battista DR; Malone MK; Weinstein RB; Shiffman S
Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):322-331. PubMed ID: 29372579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
